HugoScore hugoscore.org

Full review

Doctronic CAIHL draft report

Evidence-linked HugoScore draft report for a health AI tool that affects patients.

Agency checklist · October 30, 2026

Mixed 6 of 12 yes

Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.

Assessed function: Doctronic anonymous AI consultation (AI Tool), distinct from identified member records, paid clinician visits, and Utah prescription-renewal decisions.

A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.

  • Public documents do not establish actual product behavior.
  • The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
QuestionAnswerEvidence / reviewSource and reasoning
1. Told it is AIYesdocumented
Not independently replicated
Doctronic is an AI model trained on medical data, not a licensed doctor Source

Terms Article II also say the AI Tool 'relies on artificial-intelligence models'.

2. Operator and model maker namedNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Doctronic Inc. is named as operator. No model maker is named: the site describes 'more than 100 specialized AI agents' and a published study (arXiv 2507.22902) does not name the underlying LLMs. The privacy policy mentions vendors 'hosting and operating AI models' without names.

3. Patient chooses to use itYesdocumented
Not independently replicated
Begin immediately without signup. Simply visit doctronic.ai and start describing your health concern. Source

Free and anonymous by default. Paid telehealth is separate.

4. Patient sets the taskYesdocumented
Not independently replicated
You choose what information to include in Input, including health information Source

The user sets the question. The site also steers toward a $39 doctor visit.

5. Patient can decline or stopYesdocumented
Not independently replicated
Begin immediately without signup. Simply visit doctronic.ai and start describing your health concern. Source

Self-started tool per the Q3 source. Terms say the AI Tool is free and the paid telehealth visits are separate services with human physicians.

6. Patient sees the AI outputYesdocumented
Not independently replicated
If you have an account, you can view and download your AI Consult Summaries anytime from your dashboard. Source

Anonymous users can export a summary during a chat. After the browser is closed, the chat is gone.

7. Patient can correct or challengeNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

The policy lists a conditional 'Correction' right for inaccurate personal information, not a route to contest AI output.

8. Patient can get a copyNodocumented
Not independently replicated
If you have an account, you can view and download your AI Consult Summaries anytime from your dashboard. Source

The privacy policy also lists portability as a right that depends on where you live.

9. Patient can deleteYesdocumented
Not independently replicated
Delete your account, and poof, your data's gone from our systems. Source

This is marketing copy. Terms say the company may delete Your Content but will keep clinical and prescription-renewal records required by law. The privacy policy also lists a deletion right and says anonymous chats vanish when the browser closes.

10. Training or sale does not override patient choiceNodocumented
Not independently replicated
we may use de-identified information (including de-identified Input and Output) for any purpose, including to develop, train and evaluate AI models Source

Conflict: the our-philosophy and resource-center pages say 'We never train AI on it' and 'We never sell it. We never share it.' I answered by the binding privacy policy. No opt-out is documented. The Utah renewal service has stricter terms that do not apply to the AI Tool.

11. Patient can run it or take it elsewhereNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Vendor-hosted only. Terms also prohibit using output to train other AI.

12. No advertising or data businessNodocumented
Not independently replicated
to target, deliver and measure interest-based advertising Source

The policy says tracking-technology data goes to marketing and advertising partners in a way that 'may be considered selling or sharing'. The consumer health data policy lists measurement and marketing vendors as recipients. The 'No data sold' marketing claim conflicts with this.

Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.

Checklist rules · Independent review and limitations · Later evidence follow-up

Earlier report

Doctronic: CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

This profile covers Doctronic consumer consultation with optional clinical escalation. Patients choose the initial question and whether to seek further care. Commercial incentives require scrutiny, but this pass did not establish that users are forced toward paid care. Prescription-renewal deployments require separate assessment.

Scope and agency posture

Doctronic anonymous AI consultation, distinct from identified member records, paid clinician visits, and prescription-renewal decisions. Consumer-directed entry into a vendor-operated care platform.

Posture: Potentially agency-expanding, with vendor-funnel and framing caveats.

Axis: 75/100, retained provisionally. No numerical recalibration was performed.

Sources and documented findings

  • The homepage offers free anonymous consultation, paid doctor visits, and explicitly says users can take the result to their own doctor. Its treatment-plan pitch coexists with a footer denying medical advice by the AI.
  • The privacy notice documents human physician review on request, optional record imports, correction/export rights, and stopping provider-initiated retrieval.
  • The notice's June 18 update discloses identifiable email engagement tracking with 90-day retention. It separates anonymous use from member medical records, some retained at least seven years.

Patient authority

Inference from the documented workflow: Patients can choose questions and an outside clinician. The evidence supports an offered paid pathway, not a demonstrated forced funnel. Member treatment and renewal workflows give the operator additional responsibilities and access.

Critical capacity

Editorial assessment: Portable assessments and human review can support comparison and challenge. The source does not demonstrate that generated evidence is accurate or that a human reviewer evaluates independently.

Informed control

Editorial assessment: The policy offers unusually concrete rights, but headline clinical language and the AI disclaimer send different signals about reliance. Anonymous and identified use must not share one blanket privacy claim.

Assessment and limits

Keep the qualified agency finding while separating deployment modes. The baseline inference that the model routes users commercially exceeds the observed evidence. Tracking corrections are material factual updates.

Confidence: Medium for published choices and rights.

Remaining uncertainty: Actual anonymous unlinkability, paid-escalation presentation, independent review mechanics, citation reliability, and renewal oversight.

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

Review provenance

  • Reviewer/model: OpenAI Codex / GPT-6.
  • Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
  • Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
  • Earlier review: 2026-06-10. Historical assessment. Earlier claims are not automatically reverified by this publication.